Balance Sheet

Assets

+84%

+111%

10Y

Currency: KRW

	Dec-2003	Dec-2004	Dec-2005	Dec-2006	Dec-2007	Dec-2008	Dec-2009	Dec-2010	Dec-2011	Dec-2012	Dec-2013	Dec-2014	Dec-2015	Dec-2016	Dec-2017	Dec-2018	Dec-2019	Dec-2020	Dec-2021	Dec-2022	Dec-2023	Dec-2024
Assets
Cash & Cash Equivalents	430	50	91	428	608	1 794	2 263	1 993	2 119	1 790	2 534	518	1 422	3 522	5 473	5 488	2 350	8 639	10 113	13 226	10 796	14 517
Cash Equivalents	430	50	91	428	608	1 794	2 263	1 993	2 119	1 790	2 534	518	1 422	3 522	5 473	5 488	2 350	8 639	10 113	13 226	10 796	14 517
Short-Term Investments	0	40	1 378	0	0	3 770	6 370	6 075	2 860	213	10 400	5 851	3 404	5 096	584	5 674	5 747	12 405	5 803	84	116	140
Total Receivables	2 345	2 207	2 605	2 826	3 819	6 063	6 685	7 508	7 740	12 523	13 080	15 821	12 412	14 001	12 833	14 459	15 861	12 181	13 047	30 803	38 587	28 425
Accounts Receivables	2 305	2 070	2 500	2 618	3 651	5 831	6 303	7 434	7 704	12 344	12 910	15 057	11 706	13 358	11 407	13 278	15 059	11 570	12 422	441	474	693
Other Receivables	40	137	105	208	168	232	382	74	36	179	170	764	706	643	1 426	1 181	802	610	625	30 362	38 113	27 732
Inventory	1 360	1 397	1 809	1 996	2 178	2 313	3 326	4 752	5 680	7 187	7 937	9 241	15 698	15 620	14 632	13 159	15 173	16 963	15 276	184 409	172 698	148 517
Other Current Assets	149	370	83	70	141	489	266	703	778	1 674	1 067	6 020	1 912	8 485	10 087	1 496	2 200	1 934	3 964	10 773	14 152	13 051
Total Current Assets	4 285	4 065	5 966	5 320	6 746	14 429	18 910	21 031	19 178	23 388	35 017	37 451	34 848	46 724	43 610	40 276	41 332	52 123	48 203	250 347	258 201	227 195
PP&E Net	5 546	5 526	5 882	9 037	9 461	9 469	14 725	26 343	28 425	51 712	51 603	52 376	52 944	46 415	48 040	40 562	45 591	42 726	39 278	713	1 289	1 127
PP&E Gross	5 546	5 526	5 882	9 037	9 461	9 469	14 725	26 343	28 425	51 712	51 603	52 376	52 944	46 415	48 040	40 562	45 591	42 726	39 278	713	1 289	1 127
Accumulated Depreciation	1 437	2 040	2 771	3 516	4 493	5 531	6 582	8 627	7 460	11 965	13 919	16 429	19 416	22 379	24 515	26 043	29 440	30 786	29 429	717	811	814
Intangible Assets	1 472	2 053	1 950	1 941	2 057	2 149	1 910	2 906	3 317	8 476	8 820	6 833	7 622	8 219	5 616	6 110	6 383	1 946	854	137	134	129
Goodwill	0	0	0	0	0	0	0	524	524	630	630	872	872	524	524	524	524	524	524	1	1	0
Note Receivable	7	3	0	0	0	0	0	700	709	771	759	791	843	870	771	805	833	783	853	1 912	3 428	1 058
Long-Term Investments	479	617	651	728	1 614	3 776	4 182	400	445	16 665	18 517	14 677	14 982	15 747	17 214	6 067	6 256	6 616	7 946	23 145	28 211	28 815
Other Long-Term Assets	13	77	29	46	432	468	1 175	1 215	1 292	1 788	1 442	2 056	1 672	1 578	3 891	3 349	2 372	3 139	5 469	1 861	2 196	1 816
Other Assets	0	0	0	0	0	0	0	524	524	630	630	872	872	524	524	524	524	524	524	1	1	0
Total Assets	11 801 N/A	12 342 +5%	14 478 +17%	17 071 +18%	20 310 +19%	30 291 +49%	40 902 +35%	53 118 +30%	53 888 +1%	103 430 +92%	116 788 +13%	115 056 -1%	113 784 -1%	120 077 +6%	119 665 0%	97 693 -18%	103 292 +6%	107 856 +4%	103 128 -4%	276 203 +168%	290 032 +5%	259 083 -11%
Liabilities
Accounts Payable	140	329	480	585	929	526	526	608	430	6 058	5 711	7 188	5 901	6 782	4 198	2 843	3 466	2 561	1 922	3 699	5 558	5 641
Accrued Liabilities	10	4	71	55	34	13	60	89	186	767	605	544	1 072	1 025	1 982	1 189	1 006	911	1 169	12 265	13 487	11 512
Short-Term Debt	1 012	2 648	2 970	1 950	4 340	4 900	4 900	5 202	6 166	32 073	35 634	24 831	22 425	42 002	42 648	31 338	30 098	38 718	24 830	22 971	27 238	29 827
Current Portion of Long-Term Debt	4 244	735	886	3 046	2 742	422	508	614	4 260	1 272	7 978	7 341	18 949	2 128	1 859	1 552	347	1 353	5 720	12 879	11 040	6 107
Other Current Liabilities	413	782	468	1 010	664	2 655	2 312	1 983	2 036	2 856	3 385	5 366	3 870	4 964	4 847	3 825	4 425	3 867	4 521	131 908	145 379	126 672
Total Current Liabilities	5 819	4 499	4 874	6 647	8 709	8 517	8 305	8 496	13 079	43 027	53 315	45 269	52 218	56 900	55 533	40 748	39 343	47 410	38 161	183 721	202 701	179 759
Long-Term Debt	2 508	4 052	5 424	4 144	1 951	2 222	11 268	12 304	1 616	16 484	13 939	24 391	7 806	8 384	15 464	3 451	8 021	9 837	3 929	39 618	28 712	27 723
Deferred Income Tax	0	0	18	0	0	0	0	0	0	1 466	1 443	91	91	91	270	283	283	283	192	153	164	32
Minority Interest	0	0	0	0	0	0	0	1 110	1 102	1 055	1 049	1 259	1 131	1 236	1 265	1 338	1 595	1 547	1 775	29 182	33 153	24 025
Other Liabilities	0	0	0	15	0	0	0	81	147	1 568	3 553	1 102	1 668	1 874	1 120	1 904	783	800	747	1 069	489	16
Total Liabilities	8 327 N/A	8 551 +3%	10 317 +21%	10 806 +5%	10 660 -1%	10 739 +1%	19 573 +82%	21 992 +12%	15 944 -28%	63 599 +299%	73 298 +15%	72 112 -2%	62 913 -13%	68 486 +9%	73 653 +8%	47 723 -35%	50 024 +5%	59 878 +20%	44 805 -25%	252 674 +464%	264 729 +5%	231 555 -13%
Equity
Common Stock	1 816	1 816	1 816	2 000	2 000	2 500	2 500	7 989	8 550	8 550	8 550	9 469	10 760	10 937	10 937	11 931	11 931	11 931	11 931	3 111	3 111	3 111
Retained Earnings	306	647	1 013	2 070	5 350	7 914	10 081	6 597	7 622	13 615	15 532	10 326	10 944	11 369	7 049	5 686	8 799	4 473	13 640	18 536	20 238	22 526
Additional Paid In Capital	1 352	1 352	1 352	2 236	2 236	10 390	10 390	18 511	21 529	17 990	19 872	23 453	29 062	29 885	29 885	34 491	34 491	34 491	34 491	2 100	2 170	2 090
Unrealized Security Profit/Loss	0	25	20	41	64	723	333	0	53	87	93	126	146	225	462	488	421	388	160	253	253	239
Treasury Stock	0	0	0	0	0	1 975	1 975	1 975	0	498	498	498	498	1 323	1 483	1 979	2 111	2 778	2 778	2 842	2 842	2 982
Other Equity	0	0	0	0	0	0	0	5	297	261	127	320	749	948	85	329	578	250	879	34	36	39
Total Equity	3 474 N/A	3 791 +9%	4 161 +10%	6 265 +51%	9 650 +54%	19 553 +103%	21 329 +9%	31 126 +46%	37 944 +22%	39 831 +5%	43 490 +9%	42 944 -1%	50 870 +18%	51 591 +1%	46 011 -11%	49 970 +9%	53 267 +7%	47 978 -10%	58 323 +22%	23 529 -60%	25 302 +8%	27 528 +9%
Total Liabilities & Equity	11 801 N/A	12 342 +5%	14 478 +17%	17 071 +18%	20 310 +19%	30 291 +49%	40 902 +35%	53 118 +30%	53 888 +1%	103 430 +92%	116 788 +13%	115 056 -1%	113 784 -1%	120 077 +6%	119 665 0%	97 693 -18%	103 292 +6%	107 856 +4%	103 128 -4%	276 203 +168%	290 032 +5%	259 083 -11%
Shares Outstanding
Common Shares Outstanding	9	9	9	9	9	11	11	15	17	17	17	19	21	22	22	23	23	23	23	3 111	3 111	3 111

Income Statement Balance Sheet Cash Flow Statement

Metabiomed Co Ltd
KOSDAQ:059210

Balance Sheet

Balance Sheet Decomposition
Metabiomed Co Ltd

Balance Sheet
Metabiomed Co Ltd

See Also

Company

Help

Tools

Stocks

Metabiomed Co Ltd KOSDAQ:059210

Balance Sheet

Balance Sheet Decomposition Metabiomed Co Ltd

Balance Sheet Metabiomed Co Ltd

See Also

Company

Help

Tools

Stocks

Metabiomed Co Ltd
KOSDAQ:059210

Balance Sheet Decomposition
Metabiomed Co Ltd

Balance Sheet
Metabiomed Co Ltd